Skip to main content
. 2022 Jun 30;70(7):2240–2245. doi: 10.4103/ijo.IJO_2880_21

Table 1.

Comparison of clinical and ocular biometric characteristics between nanophthalmos (NO) group and control (CO) group

NO group CO group P a
Number of subjects 40 30 -
Age, years 8.95 (4.0) 10.47 (3.0) 0.089
Female gender, n (%) 22 (55.0) 14 (46.7) 0.490b
UCVA, logMAR
 Median (Snellen’s equivalent) 1.18 (4/60) 0 (6/6) <0.001c
 IQR 1.08 to 1.48 0 to 0
BCVA, logMAR
 Median (Snellen’s equivalent) 0.60 (6/24) 0 (6/6) <0.001c
 IQR 0.30 to 0.78 0 to 0
Spherical equivalent, D 10.87 (3.1) 0.19 (0.7) <0.001
Axial length, mm 16.67 (1.3) 22.91 (0.9) <0.001
ACD, mm 2.50 (0.3) 3.47 (0.3) <0.001
Lens thickness, mm 3.64 (0.5) 3.36 (0.2) 0.005
CCT, mm 537.90 (43.1) 542.57 (31.4) 0.713
RCS thickness, mm 2.01 (0.2) 1.52 (0.1) <0.001
Keratometry, D
 Kf 48.56 (2.4) 43.52 (1.3) <0.001
 Ks 49.51 (2.2) 44.58 (1.7) <0.001
 Astigmatism 1.03 (0.5) 1.09 (0.7) 0.785
Lens axial length factor 2.19 (0.3) 1.47 (0.1) <0.001
LT/ACD 1.47 (0.2) 0.97 (0.1) <0.001

UCVA, uncorrected visual acuity; BCVA, best-corrected visual acuity; Kf, keratometry in flat meridian; Ks, keratometry in steep meridian; LAF, lens axial length factor=LT/AXL ×10; ACD, anterior chamber depth; RCS, retinochoroidal scleral thickness; CCT, central corneal thickness; IQR, interquartile range; logMAR, logarithm of minimal angle of resolution. aIndependent t-test; bChi-square test/Fisher’s exact test; cMann-Whitney U test